This Opposition was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on October 19, 2022 and assigned serial number 91281267 by the TTAB.

Defendant:
Genesis Drug, Discovery & Development, LLC represented by ARNOLD BRAUN of GENESIS BIOTECHNOLOGY GROUP.
Trademark Information: HELIX CONNECT – US Trademark Serial Number 88641546
View Trademark Status at USPTO
View Trademark Documents at USPTO

Plaintiff:
Helix OpCo, LLC represented by JAMI GEKAS of FOLEY & LARDNER LLP.
Trademark Information: HELIX – US Trademark Serial Number 78311374
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
October 19, 2022 – FILED AND FEE
October 19, 2022 – NOTICE AND TRIAL DATES SENT; ANSWER DUE:
October 19, 2022 – INSTITUTED
November 01, 2022 – D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
November 01, 2022 – SUSPENDED
November 28, 2022 – D MOT FOR EXT W/ CONSENT
November 28, 2022 – EXTENSION OF TIME GRANTED
January 24, 2023 – D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
January 24, 2023 – SUSPENDED
February 01, 2023 – W/DRAW OF APPLICATION
February 01, 2023 – BD DECISION: OPP DISMISSED W/ PREJ
February 01, 2023 – TERMINATED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.